Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.59 | 14514962 11752688 15322242 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.65 | 17418594 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.98 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
4.12 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
5.13 | 21441931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.39 | 11748828 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.89 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.53 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.66 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
3.02 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.57 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.26 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.07 | 15939500 15634643 15136595 16115903 18628466 19526202 16264153 16595493 16096432 17983394 15567936 11325840 15692762 16935488 17426702 17369602 18695136 18234424 15993339 15668708 16826403 18382427 16322301 15994142 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.07 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.68 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
3.28 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
3.28 | 16023760 16234567 17876044 18059187 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
7.12 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
7.12 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.73 | 6189445 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.58 | 16120746 18670907 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.80 | 16278810 17351982 17928571 17974986 16455267 18627295 15792986 17924179 15811867 17519947 16952015 15476868 16242529 15505089 17007740 17308081 17329180 17382496 16612575 16731534 16364871 16269455 17131338 16109756 16651473 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.06 | 17334414 16243910 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
3.05 | 7505956 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.58 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.47 | 19486331 9022650 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.25 | 8697196 12621046 16354765 15668235 15340226 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.15 | 18802399 18259882 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.27 | 10048152 20055451 15322242 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
3.44 | 14531868 11906362 11298694 2524372 8156756 8970840 12868966 18759878 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
4.02 | 3621924 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.74 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
6.83 | 6679447 18692083 18648102 18289764 1440618 9653073 16192314 8291058 7440962 9022650 11289319 6482804 9328219 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.83 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.83 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
9.21 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
9.21 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.85 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.77 | 18230668 15322242 16714409 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.72 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.47 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
6.02 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.19 | 3581430 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 11564622 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
4.11 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.89 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
5.33 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.60 | 20067830 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.61 | 17150277 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.57 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.46 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.81 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.53 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.78 | 16244371 17875725 18674790 16244372 16144979 16495754 17888722 18006777 12587719 16879835 14766674 16330681 16707910 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.59 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.38 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.82 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
4.10 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.54 | 15340226 12621046 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.82 | 18501091 17606976 15147373 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.91 | 15340226 16354765 8697196 16959395 18606429 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.59 | 15034207 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.03 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
2.04 | 12200463 12878042 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.89 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.28 | 15699352 16775033 15369732 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.64 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
3.35 | 6582329 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
6.02 | 16085563 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.44 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.53 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.53 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.84 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
11.34 | 6587162 598648 1399818 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
11.34 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
11.34 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.49 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.49 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.77 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
4.18 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
5.22 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.29 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.33 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.20 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.98 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.53 | 17415656 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.09 | 19429709 15857846 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.38 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
6.32 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.32 | 18259882 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.42 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.42 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.80 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
3.18 | 6679447 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.45 | 15555623 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.87 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.89 | 3988306 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.48 | 15930896 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
4.13 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
5.12 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
5.34 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
6.02 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
6.02 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
4.14 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.93 | 11118676 11222880 11896295 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.49 | 16888761 16729912 15749863 18437689 15897917 16868541 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.87 | 17922066 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.42 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.70 | 3692021 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.44 | 15675481 15625365 17710206 17203757 16767912 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.83 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.53 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
6.27 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
6.27 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
5.22 | 16767912 15625365 17203757 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.77 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
8.42 | 3712494 7505956 1399818 6587162 6582329 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
8.42 | 17909728 16010429 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
5.65 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.65 | 17653716 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.46 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.87 | 17334414 16364871 17638931 17678736 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
5.12 | 15886252 |